Swedish Registry Data Reveal 6-Factor Genetic Structure for Psychiatric Disorders

Unpacking the Genetic Architecture of Psychiatric Illness

Psychiatric disorders represent a significant global health burden, contributing substantially to years lived with disability and impacting millions of patients [1]. Conditions such as major depression [2], anxiety disorders, and neurodevelopmental disorders like autism spectrum disorder [3] are highly prevalent and frequently co-occur, profoundly affecting quality of life. While environmental factors like childhood adversity are established contributors [4, 5], a substantial genetic component is recognized across many of these conditions, including less common ones like trichotillomania and excoriation disorder [6]. The precise structure of these genetic risks, particularly how they overlap or diverge across different diagnoses, has remained a critical question. A recent large-scale study provides a more detailed map of the intricate genetic relationships among a wide array of psychiatric and substance use disorders.

A Robust Population-Level View of Genetic Risk

Previous efforts to map the genetic architecture of psychiatric illness have often relied on molecular samples from diverse sources, using varied diagnostic methods that can limit the clarity of the findings. To create a more unified picture, a new study assessed the structure of genetic risk for 18 psychiatric and substance use disorders within a single, well-defined national population. The analysis leveraged high-quality Swedish population registries, providing a complete epidemiological frame that minimizes the selection biases common in other research designs. The cohort included 3,021,948 individuals born in Sweden between 1960 and 2000, followed for a mean of 40.9 (10.5) years. Of the participants, 1,549,159 (51.3%) were male.

To quantify inherited risk without direct DNA analysis, the researchers calculated family genetic risk scores (FGRSs) for each individual. These scores estimate a person's genetic liability for a disorder based on diagnoses in their relatives, extending from first-degree (parents, siblings, children) to fifth-degree relatives, while statistically controlling for the influence of shared household environments. The investigators then used a two-step statistical approach on split-half samples to ensure the findings were robust. First, they applied exploratory factor analysis (EFA), a method for discovering underlying patterns by seeing how genetic risks for different disorders cluster together. Second, they used confirmatory factor analysis (CFA) to formally test how well their proposed model of clustered risks fit the data. This combination of a massive, high-quality dataset and rigorous statistical validation provides an exceptionally strong foundation for understanding shared genetic vulnerabilities.

Six Core Genetic Factors Emerge

The analysis revealed that the genetic risks for 18 different psychiatric and substance use disorders are not randomly distributed but instead organize into a 6-factor structure. These six distinct, yet related, clusters of shared genetic vulnerability were identified as: psychotic disorders, externalizing disorders, anxiety disorders, neurodevelopmental disorders, mood disorders, and eating disorders. The mean interfactor correlation, a measure of the average genetic overlap between these six clusters, was 0.29, indicating a modest but significant degree of interconnectedness. This suggests that while these domains are genetically distinct, they are not entirely independent.

To validate this model, the researchers performed a confirmatory factor analysis, which demonstrated a good statistical fit for the 6-factor structure. A key finding was that the model set 70.3% of the genetic risk loadings to zero. In clinical terms, this means that the genetic risk for most individual disorders mapped cleanly onto one or two of the six factors, rather than being diffusely spread across all of them. This finding suggests a more specific genetic architecture than previously understood, offering a clearer framework for how different psychiatric conditions are related at a biological level. Such a framework could eventually support a diagnostic system based on underlying biology in addition to clinical symptoms.

Nuances in Shared Genetic Vulnerabilities

The study provided several specific insights relevant to clinical practice. For instance, the analysis identified separate genetic factors for mood and anxiety disorders. However, it also found that major depression loaded onto both the mood and anxiety factors, providing a genetic correlate for the high rate of comorbidity observed between these conditions in the clinic. This suggests a shared genetic substrate that may predispose individuals to both depressive and anxious symptomatology.

Further complexity was evident in the relationship between mood and psychotic disorders. Bipolar disorder, schizoaffective disorder, and acute psychoses all showed genetic loading on both the mood and psychotic disorder factors, supporting the concept of a clinical spectrum. Critically, the analysis also revealed distinguishing patterns: for bipolar disorder, the loading on the mood factor was stronger than on the psychotic factor. In contrast, the reverse was true for schizoaffective disorder and acute psychotic disorder, which loaded more heavily on the psychotic factor. This genetic differentiation mirrors the clinical challenges in diagnosing these conditions and may point toward distinct underlying pathophysiologies despite symptomatic overlap.

The findings also clarified the genetic architecture of other complex conditions. Posttraumatic stress disorder (PTSD) demonstrated the most diverse genetic signature, with loadings on the mood, anxiety, and externalizing disorder factors. This broad genetic footprint aligns with the multifaceted clinical presentation of PTSD, which can include symptoms of depression, anxiety, and impulsivity. Furthermore, attention-deficit/hyperactivity disorder (ADHD) loaded on both the neurodevelopmental and externalizing factors, providing a genetic basis for its dual classification as a disorder of brain development that often manifests with behavioral dysregulation.

Methodological Rigor and Clinical Implications

The researchers took specific steps to ensure the integrity of their results. Because family genetic risk scores can be statistically skewed, especially for rare disorders, they applied a range of data transformations to normalize the distributions. Reassuringly, these adjustments produced results similar to those from the original data, strengthening confidence in the stability and reliability of the identified 6-factor genetic structure.

By using a complete epidemiological ascertainment of treated disorders in a large, well-documented population, this cohort study has produced a refined map of the genetic architecture of psychiatric illness. While confirming some findings from previous research, it also revealed important differences, such as the specific patterns of genetic overlap for conditions like bipolar disorder and PTSD. For practicing physicians, this work reinforces the biological interconnectedness of psychiatric disorders frequently seen as comorbid in patients. A clearer delineation of these genetic factors may ultimately inform future diagnostic classifications, improve patient risk stratification, and guide the development of more targeted interventions that address shared biological pathways rather than single diagnostic labels.

References

1. Ferrari AJ, Santomauro D, Aali A, et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2024. doi:10.1016/s0140-6736(24)00757-8

2. Howard DM, Adams MJ, Clarke T, et al. Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions. Nature Neuroscience. 2019. doi:10.1038/s41593-018-0326-7

3. Baio J, Wiggins LD, Christensen D, et al. Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. MMWR Surveillance Summaries. 2018. doi:10.15585/mmwr.ss6706a1

4. Norman R, Byambaa M, De R, Butchart A, Scott JG, Vos T. The Long-Term Health Consequences of Child Physical Abuse, Emotional Abuse, and Neglect: A Systematic Review and Meta-Analysis. PLoS Medicine. 2012. doi:10.1371/journal.pmed.1001349

5. Varese F, Smeets F, Drukker M, et al. Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies. Schizophrenia Bulletin. 2012. doi:10.1093/schbul/sbs050

6. Reid M, Lin A, Farhat LC, Fernandez TV, Olfson E. The genetics of trichotillomania and excoriation disorder: A systematic review.. Comprehensive psychiatry. 2024. doi:10.1016/j.comppsych.2024.152506